▪ Abstract Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic-helix-loop-helix-PAS transcription factor consisting of HIF-1α and HIF-1β subunits. HIF-1α expression and HIF-1 transcriptional activity increase exponentially as cellular O 2 concentration is decreased. Several dozen target genes that are transactivated by HIF-1 have been identified, including those encoding erythropoietin, glucose transporters, glycolytic enzymes, and vascular endothelial growth factor. The products of these genes either increase O 2 delivery or allow metabolic adaptation to reduced O 2 availability. HIF-1 is required for cardiac and vascular development and embryonic survival. In fetal and postnatal life, HIF-1 is required for a variety of physiological responses to chronic hypoxia. HIF-1 expression is increased in tumor cells by multiple mechanisms and may mediate adaptation to hypoxia that is critical for tumor progression. HIF-1 thus appears to function as a master regulator of O 2 homeostasis that plays essential roles in cellular and systemic physiology, development, and pathophysiology.
Narayan V. Iyer, Lori E. Kotch, Faton Agani, Sandra W. Leung, Erik Laughner, Roland H. Wenger, Max Gassmann, John D. Gearhart, Ann M. Lawler, Aimee Y. Yu, Gregg L. Friedman
Rajani Ravi, Bijoyesh Mookerjee, Zaver M. Bhujwalla, Thomas R. Sutter, Dmitri Artemov, Qinwen Zeng, Larry E. Dillehay, Ashima Madan, Gregg L. Friedman, Atul Bedi
Discussion(0)
No comments yet. Be the first to comment.